Search results for "confidence interval"

showing 10 items of 1297 documents

Physical activity in adolescence and smoking in young adulthood: a prospective twin cohort study.

2007

Aims  To control for familial confounds, we studied the association between adolescent physical activity and later smoking in twin siblings discordant for their baseline physical activity. Design and measurements  In this prospective population-based twin study, we asked whether persistent physical activity/inactivity in adolescence (assessed at 16, 17 and 18.5 years) predicted questionnaire-reported daily smoking at ages 22–27. Twins who, on the three baseline questionnaires, consistently reported frequent leisure physical activity (more than three times weekly) were classified as persistent exercisers, those who exercised less than three times monthly were called persistently inactive, ot…

AdultMalemedicine.medical_specialtyAdolescentPopulationHealth Behaviorphysical activityMedicine (miscellaneous)Smoking PreventionliikuntaArticleCohort Studies03 medical and health sciences0302 clinical medicinetupakointiRisk FactorsmedicineTwins DizygoticHumans030212 general & internal medicineProspective StudiesYoung adultProspective cohort studyeducationPsychiatryExerciseFinlandnuoret aikuisetDiscordant Twineducation.field_of_studyexerciseSmokingOdds ratioTwins MonozygoticTwin studyConfidence intervalkaksosetPsychiatry and Mental healthAdolescent BehaviorFemalePsychologyAttitude to Health030217 neurology & neurosurgeryCohort studyDemographyFollow-Up StudiesAddiction (Abingdon, England)
researchProduct

Screening for DSM-5 Somatic Symptom Disorder: Diagnostic Accuracy of Self-Report Measures Within a Population Sample.

2017

OBJECTIVE The new DSM-5 somatic symptom disorder was introduced to improve the diagnosis of persons experiencing what used to be called somatoform disorders. So far, it is unclear whether existing self-report measures are useful to detect the new somatic symptom disorder. This study investigates the diagnostic accuracy of three self-report questionnaires that measure somatic complaints (15 item Patient Health Questionnaire [PHQ-15]) and psychological features (7-item Whiteley Index [WI-7]; Scale for Assessing Illness Behavior [SAIB]), in detecting somatic symptom disorder. METHODS A nationally representative general population survey was performed resulting in 250 participants (minimum age …

AdultMalemedicine.medical_specialtyAdolescentSomatic symptom disorderSensitivity and SpecificityDSM-503 medical and health sciencesYoung Adult0302 clinical medicineSelf-report studyInternal medicinemedicineHumans030212 general & internal medicineLongitudinal StudiesYoung adultPsychiatrySomatoform DisordersApplied PsychologyAgedPsychiatric Status Rating ScalesReceiver operating characteristicbusiness.industryArea under the curveMiddle Agedmedicine.diseaseConfidence intervalPatient Health QuestionnaireDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthMedically Unexplained SymptomsFemaleSelf Reportbusiness030217 neurology & neurosurgeryPsychosomatic medicine
researchProduct

Sedentariness and weight status related to SES and family characteristics in Italian adults: exploring geographic variability through multilevel mode…

2017

Aim: In this study, our aim was to assess the prevalence of sedentariness and overweight/obesity, two modifiable risk factors for non-communicable diseases (NCDs), and to investigate the geographic variability in their association with socio-economic status (SES) and family characteristics in Italian adults. Methods: The Multipurpose Survey on Health Conditions and the Recourse to Health Services (MSHC), 2012/2013 edition, conducted by the National Institute of Statistics was used as data source. The sample for this study included 99,479 interviewed people aged 18 and over, which are representative of about 50 million persons. For the scope of this analysis, data were considered as individ…

AdultMalemedicine.medical_specialtyAdolescentfamily characteristic030209 endocrinology & metabolismOverweightBMI; family characteristics; multilevel models; non-communicable diseases; overweight/obesity; Sedentariness; SES; Public Health Environmental and Occupational HealthSettore MED/01 - Statistica Medica03 medical and health sciencesYoung AdultBMI0302 clinical medicineRisk FactorsmedicineHumans030212 general & internal medicineObesitynon-communicable diseaseSedentarineSedentary lifestyleAgedFamily Characteristicsbusiness.industryPublic healthMultilevel modelPublic Health Environmental and Occupational HealthGeneral MedicineOdds ratioMiddle AgedOverweightoverweight/obesitymedicine.diseaseObesityConfidence intervalmultilevel modelLogistic ModelsItalySocial ClassMultilevel AnalysisFemalemedicine.symptomSedentary BehaviorbusinessSESBody mass indexDemography
researchProduct

Low Cross-Reactivity Between Cisplatin and Other Platinum Salts.

2019

Background Hypersensitivity reactions to platinum salts (PS) (cisplatin [CI], carboplatin [CA], and oxaliplatin [OX]) can be severe and their incidence is increasing due to their widespread use in cancer treatment. Objective To determine the rate of cross-reactivity between PS and whether CI can be administered without prior allergy testing in patients with a history of CA or OX hypersensitivity. Methods From September 2002 to April 2016, patients with suspected immediate PS hypersensitivity were tested and cross-reactivity between the 3 PS was evaluated. We then studied patients who were given CI without desensitization after immediate hypersensitivity to other PS. Results A total of 155 p…

AdultMalemedicine.medical_specialtyAllergymedicine.medical_treatment[SDV]Life Sciences [q-bio]Antineoplastic AgentsPlatinum CompoundsCross ReactionsGastroenterologyCarboplatinDrug Hypersensitivity03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineNeoplasmsImmunology and AllergyMedicineHumans030212 general & internal medicineDesensitization (medicine)AgedSkin TestsCisplatinAged 80 and overChemotherapybusiness.industryMiddle Agedmedicine.diseaseConfidence intervalCarboplatin3. Good healthOxaliplatinOxaliplatin030228 respiratory systemchemistryFemaleSaltsbusinessAnaphylaxismedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct

Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease

1992

A randomized, placebo-controlled multicenter trial was conducted to evaluate the efficacy and safety of a delayed-release formulation of 5-aminosalicylic acid (5-ASA) (Asacol; GiulianiBracco, Milan, Italy) for prevention of clinical relapse in 125 patients with inactive Crohn's disease. Patients in remission [Crohn's Disease Activity Index (CDAI) less than 150] between 3 months and 2 years were randomly allocated to receive either 800 mg 5-ASA three times daily (n = 64) or placebo (n = 61) for up to 12 months or until relapse of symptoms. Relapse was defined by a CDAI greater than 150, with a minimum increase of 100 points over the baseline value. The cumulative relapse rates were 12% in th…

AdultMalemedicine.medical_specialtyAminosalicylic acidAdolescentmedicine.medical_treatmentPlaceboGastroenterologychemistry.chemical_compoundCrohn DiseaseInternal medicineMulticenter trialHumansMedicineIleitisMesalamineAdverse effectAgedCrohn's diseaseHepatologybusiness.industryGastroenterologyBowel resectionMiddle AgedPrognosismedicine.diseaseConfidence intervalSurgeryAminosalicylic AcidschemistryPatient ComplianceFemalebusinessGastroenterology
researchProduct

Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study.

2012

Summary.  Background:  Little information is available on the long-term clinical outcome of cerebral vein thrombosis (CVT). Objectives and methods:  In an international, retrospective cohort study, we assessed the long-term rates of mortality, residual disability and recurrent venous thromboembolism (VTE) in a cohort of patients with a first CVT episode. Results:  Seven hundred and six patients (73.7% females) with CVT were included. Patients were followed for a total of 3171 patient-years. Median follow-up was 40 months (range 6, 297 months). At the end of follow-up, 20 patients had died (2.8%). The outcome was generally good: 89.1% of patients had a complete recovery (modified Rankin Scor…

AdultMalemedicine.medical_specialtyAnticoagulant treatment; Cerebral vein thrombosis; Mortality; Recurrence; Adult; Cerebral Veins; Cohort Studies; Female; Humans; Male; Middle Aged; Recurrence; ThrombosisCohort StudiesAnticoagulant treatment; Cerebral vein thrombosis; Mortality; RecurrenceRecurrenceInternal medicinemedicineRisk of mortalityHumansMED/41 - ANESTESIOLOGIAMortalitybusiness.industryIncidence (epidemiology)Cerebral Vein thrombosiHazard ratioCerebral VeinRetrospective cohort studyThrombosisHematologyMiddle Agedmedicine.diseaseThrombosisCerebral VeinsConfidence intervalSurgerycerebral vein thrombosisSettore MED/15 - MALATTIE DEL SANGUEThrombosiCohortFemaleAnticoagulant treatmentCohort StudiebusinessHumanCohort studyJournal of thrombosis and haemostasis : JTH
researchProduct

Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study.

2020

Aim We aimed to identify whether lifetime cocaine use is a risk factor for conversion from major depressive disorder (MDD) to bipolar disorder (BD) in an outpatient sample of adults. Methods This prospective cohort study included 585 subjects aged 18 to 60 years who had been diagnosed with MDD as assessed by the Mini International Neuropsychiatric Interview (MINI-Plus) at baseline (2012-2015). Subjects were reassessed a mean of 3 years later (2017-2018) for potential conversion to BD as assessed by the MINI-Plus. Lifetime cocaine use was assessed using the Alcohol, Smoking, and Substance Involvement Screening Test. Results In the second wave, we had 117 (20%) losses, and 468 patients were r…

AdultMalemedicine.medical_specialtyBipolar DisorderAdolescentPoison control03 medical and health sciencesCocaine-Related DisordersYoung Adult0302 clinical medicineRisk FactorsInternal medicinemedicineHumansBipolar disorderProspective StudiesRisk factorProspective cohort studyMini-international neuropsychiatric interviewDepressive Disorder Majorbusiness.industryGeneral NeuroscienceGeneral MedicineMiddle Agedmedicine.diseaseConfidence interval030227 psychiatryPsychiatry and Mental healthNeurologyCohortDisease ProgressionMajor depressive disorderFemaleNeurology (clinical)business030217 neurology & neurosurgeryPsychiatry and clinical neurosciencesReferences
researchProduct

Noninvasive peripheral vascular function and atrial fibrillation in the general population.

2019

Background Arterial stiffness is a strong predictor of atrial fibrillation in the community. Whether noninvasively measured conduit artery function and peripheral vascular reactivity are related to atrial fibrillation remains unknown. Methods and results In 15 010 individuals of the population-based Gutenberg Health Study, mean age 55 ± 11 years, 50.5% men, we determined noninvasive vascular function by flow-mediated dilation (FMD) and peripheral arterial tonometry (PAT) in relation to manifest atrial fibrillation (N = 466). Patients with atrial fibrillation exhibited a higher mean brachial artery diameter [4.81 mm (4.17, 5.33) in atrial fibrillation vs. 4.31 mm (3.67, 4.93)] and baseline p…

AdultMalemedicine.medical_specialtyBrachial ArteryPhysiologyManometryArbitrary unitPopulation030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineVascular StiffnessRisk FactorsInternal medicinemedicine.arteryAtrial FibrillationInternal MedicinemedicineHumanscardiovascular diseases030212 general & internal medicineBrachial arteryeducationAgededucation.field_of_studybusiness.industryAtrial fibrillationOdds ratioMiddle Agedmedicine.diseaseConfidence intervalVasodilationmedicine.anatomical_structurecardiovascular systemCardiologyArterial stiffnessFemaleCardiology and Cardiovascular MedicinebusinessArteryJournal of hypertension
researchProduct

Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular weight heparin.

2009

Introduction: We tested the efficacy and safety of fixed doses of Low-Molecular Weight Heparin (LMWH) in patients requiring interruption of Vitamin-k Antagonist (VKA) because of invasive procedures Methodology: Pre-operatively, patients discontinued VKA 5 +/- 1days; in those at low-risk for thrombosis, LMWH was given at a prophylactic dosage of 3.800 U.I. (nadroparin) or 4.000 U.I. (enoxaparin) anti-FXa once daily the night before the procedure. In patients at high-risk for thrombosis, LMWH was started early after VKA cessation and given at fixed sub-therapeutic doses (3.800 or 4.000 UI anti-FXa twice daily) until surgery. Post-operatively, LMWH was reinitiated 12 hours after procedure whil…

AdultMalemedicine.medical_specialtyBridging low molecular weight heparinTime FactorsVitamin Kmedicine.drug_classLow molecular weight heparinAdministration OralPostoperative HemorrhageRisk AssessmentDrug Administration ScheduleSettore MED/15 - Malattie Del SangueRisk FactorsThromboembolismmedicineHumansProspective StudiesEnoxaparinProspective cohort studyAgedAged 80 and overbusiness.industryIncidence (epidemiology)WarfarinAnticoagulantsNadroparinHematologyHeparinHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryLow Molecular Weight Heparin Fixed doses Chronic oral anticoagulation perioperative bridgingAnesthesiaSurgical Procedures OperativeNadroparinFeasibility StudiesFemaleWarfarinbusinessmedicine.drugFactor Xa Inhibitors
researchProduct

A 30-Year, Population-Based Study Shows Improved Management and Prognosis of Hepatocellular Carcinoma

2010

Background & Aims Little is known about the impact of changes in the management of hepatocellular carcinoma (HCC) over time. We assessed trends in the pattern of care and in prognosis at a population level. Methods Data on diagnostic conditions, treatment, and prognosis from 1976–2005 were collected by the population-based digestive cancer registry of Burgundy (France). A nonconditional logistic regression was used to identify factors associated with treatment for cure. A multivariate relative survival analysis was also performed. Results The context of HCC diagnosis has changed; the proportion of asymptomatic patients increased from 5.6% (1976–1985) to 37.2% (1996–2005). The proportion of …

AdultMalemedicine.medical_specialtyCarcinoma HepatocellularPopulationContext (language use)Logistic regressionAsymptomaticInternal medicineEpidemiologymedicineHumanseducationAgedUltrasonographyAged 80 and overeducation.field_of_studyHepatologyRelative survivalHistocytochemistrybusiness.industryGastroenterologyMiddle AgedPrognosismedicine.diseaseSurvival AnalysisConfidence intervalSurgeryRadiographyTreatment OutcomeHepatocellular carcinomaFemaleFrancemedicine.symptombusinessClinical Gastroenterology and Hepatology
researchProduct